Literature DB >> 24776714

ADHD, Conduct Disorder, Substance Use Disorder, and Nonprescription Stimulant Use.

Judith S Brook1, Elinor B Balka1, Chenshu Zhang1, David W Brook1.   

Abstract

OBJECTIVE: To assess whether the relationship of an ADHD diagnosis by adolescence to nonprescription stimulant use in adulthood is direct or indirect, via Conduct Disorder (CD) and/or Substance Use Disorder (SUD).
METHOD: Data were obtained from multiple waves of interviews and questionnaires completed by 551 community-based participants when they were between the mean ages of 14.1 and 36.6 years.
RESULTS: The results of the structural equation model (SEM) supported both a direct association between early ADHD and later nonprescription stimulant use ( B = .18, z = 2.74) and the relationship from ADHD to later nonprescription stimulant use ( B = .01, z = 1.72) via CD and SUD.
CONCLUSION: The longitudinal data supporting these paths suggest that efforts to prevent and treat the misuse of nonprescription stimulants may be more effective if attention is paid to those with a history of ADHD, as well as to those who also had CD and SUD.

Entities:  

Keywords:  ADHD; CD; SUD; nonprescription stimulants

Mesh:

Substances:

Year:  2014        PMID: 24776714      PMCID: PMC4212001          DOI: 10.1177/1087054714528535

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  29 in total

1.  Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.

Authors:  Russell A Barkley; Mariellen Fischer; Lori Smallish; Kenneth Fletcher
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

2.  An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations.

Authors:  Crystal L Dussault; Lisa L Weyandt
Journal:  J Atten Disord       Date:  2011-12-05       Impact factor: 3.256

Review 3.  Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective.

Authors:  Thomas Frodl
Journal:  J Atten Disord       Date:  2010-05-21       Impact factor: 3.256

4.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

Review 5.  Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses.

Authors:  Alice Charach; Emanuela Yeung; Troy Climans; Erin Lillie
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-12-03       Impact factor: 8.829

6.  Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults.

Authors:  Himanshu P Upadhyaya; Kelly Rose; Wei Wang; Kathleen O'Rourke; Brian Sullivan; Deborah Deas; Kathleen T Brady
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-10       Impact factor: 2.576

7.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

Review 8.  Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

Authors:  Timothy E Wilens; Lenard A Adler; Jill Adams; Stephanie Sgambati; John Rotrosen; Robert Sawtelle; Linsey Utzinger; Steven Fusillo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

9.  Evaluating dopamine reward pathway in ADHD: clinical implications.

Authors:  Nora D Volkow; Gene-Jack Wang; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank Telang; Joanna S Fowler; Wei Zhu; Jean Logan; Yeming Ma; Kith Pradhan; Christopher Wong; James M Swanson
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

10.  Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse.

Authors:  Christine T Sweeney; Mark A Sembower; Michelle D Ertischek; Saul Shiffman; Sidney H Schnoll
Journal:  J Addict Dis       Date:  2013
View more
  1 in total

1.  ADGRL3 (LPHN3) variants predict substance use disorder.

Authors:  Mauricio Arcos-Burgos; Jorge I Vélez; Ariel F Martinez; Marta Ribasés; Josep A Ramos-Quiroga; Cristina Sánchez-Mora; Vanesa Richarte; Carlos Roncero; Bru Cormand; Noelia Fernández-Castillo; Miguel Casas; Francisco Lopera; David A Pineda; Juan D Palacio; Johan E Acosta-López; Martha L Cervantes-Henriquez; Manuel G Sánchez-Rojas; Pedro J Puentes-Rozo; Brooke S G Molina; Margaret T Boden; Deeann Wallis; Brett Lidbury; Saul Newman; Simon Easteal; James Swanson; Hardip Patel; Nora Volkow; Maria T Acosta; Francisco X Castellanos; Jose de Leon; Claudio A Mastronardi; Maximilian Muenke
Journal:  Transl Psychiatry       Date:  2019-01-29       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.